Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL4920951

Clc1ccccc1-c1nnc(-c2cccnc2)o1.O=C(O)C(F)(F)F

nearest known ligand 0.76

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 10/20 0.76
RAB9A P51151 9/20 0.76
TP53 P04637 6/20 0.54
GAA P10253 2/20 0.54
SMN1; SMN2 Q16637 5/20 0.53
KDM4E B2RXH2 3/20 0.53
USP2 O75604 1/20 0.53
HPGD P15428 2/20 0.50
HSD17B10 Q99714 3/20 0.49
ALDH1A1 P00352 3/20 0.49
TSHR P16473 2/20 0.49
NFKB1 P19838 1/20 0.49
CASP3 P42574 1/20 0.49
NFKB2 Q00653 1/20 0.49
RELA Q04206 1/20 0.49
SENP8 Q96LD8 1/20 0.49
SENP7 Q9BQF6 1/20 0.49
SENP6 Q9GZR1 1/20 0.49
EGFR P00533 1/20 0.47
PTGS2 P35354 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL4919398 0.87 NPC1 (0.60) NPC1RAB9ATP53GAASMN1; SMN2
Trifluoroacetic Acid SCHEMBL4928621 0.87 NPC1 (0.57) NPC1RAB9ATP53GAASMN1; SMN2
SCHEMBL1422987 0.87 NPC1 (1.00) NPC1RAB9ATP53GAASMN1; SMN2
Trifluoroacetic Acid SCHEMBL4925968 0.87 NPC1 (0.55) NPC1RAB9ATP53GAASMN1; SMN2
Trifluoroacetic Acid SCHEMBL4925766 0.87 NPC1 (0.55) NPC1RAB9ATP53GAASMN1; SMN2
Trifluoroacetic Acid SCHEMBL3633144 0.86 NPC1 (0.54) NPC1RAB9ATP53GAASMN1; SMN2
Trifluoroacetic Acid SCHEMBL3635459 0.86 NPC1 (0.58) NPC1RAB9ATP53GAASMN1; SMN2
Trifluoroacetic Acid SCHEMBL3633019 0.86 NPC1 (0.76) NPC1RAB9ATP53GAASMN1; SMN2
Trifluoroacetic Acid SCHEMBL3631223 0.85 NPC1 (0.58) NPC1RAB9ATP53GAASMN1; SMN2
Trifluoroacetic Acid SCHEMBL3627745 0.85 NPC1 (0.55) NPC1RAB9ATP53GAASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080255203-A1 HETEROCYCLIC COMPOUNDS AND THEIR METHODS OF USE ABBOTT LABORATORIES (US) 2008-10-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080255203-A1 HETEROCYCLIC COMPOUNDS AND THEIR METHODS OF USE CYP11B2, AADAC, CYP11B1 NPC1 473/4885RAB9A 3859/4885TP53 950/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.